CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 56 enrolled
Drug / intervention
Gabapentin +1 moredrug
Likely dose
Gabapentin 900mgfrom record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT01143766
NCT01143766N/ACompleted
CompareCT.gov

Premedication With Single Dose Gabapentin to Improve Patient Tolerance in ERCP: A Double-Blind Randomized Controlled Trial

Indiana University·interventional·Posted Jun 14, 2010·Updated Sep 28, 2023

In Brief

A clinical study evaluating Gabapentin and Standard sedation regimen for Conscious Sedation. Completed, enrolled 56 participants across 1 site.

Detailed Summary

The standard approach to sedation in endoscopic retrograde cholangiopancreatography (ERCP) involves the use of benzodiazepines and opiates to achieve a moderate depth of sedation. There is data to suggest supplementing this regimen with gabapentin may lead to reduced pain, higher patient satisfaction and lower opiate requirements. The investigators are conducting a clinical trial to study this hypothesis.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsConscious Sedation
CountriesUnited States
Collaborators--

Timeline

N/ACompletedFinished
20102011201220132014201520162017201820192020202120222023202420252026
First PostedJun 14, 2010
Enrollment StartApr 1, 2010
Primary CompletionDec 1, 2011
TodayJul 2, 2026
Enrollment to primary: 1.7 yearsPosted 16.1 years ago

Interventions

Gabapentindrug

gabapentin 900mg PO x 1 dose, 1 hour prior to the procedure

Standard sedation regimenother

Combination opiate and benzodiazepine will be administered to achieve moderate sedation. This is the standard of care.